Kaushal Sharma

I just want to understand that you suggested that you have passed on the prices. But if I see your quarter-on-quarter market, your revenue growth, your revenue growth is around 46.3%, but your gross profit is around 12% and EBITDA is around 16%. So there is some cost absorption. So there is a drop in gross margin from 46.60% to 41.31%. So what is the reason of this?

And could you please explain what kind of value-added products in pharma that we are going to launch or planning to launch [inaudible 0:19:49]?

What kind of EBITDA margin?